ICL Israel Chemicals Ltd (United States) is listed on the Nasdaq and has a market capitalization of $7.57 billion, with shareholders equity totaling $6.44 billion.
The company employs approximately 12.000 people and operates in the Others sector, within the Others industry.
Over the past 12 months, ICL Israel Chemicals Ltd reported $7.71 billion in revenue, generating net income of $305.00 million.
Key financial metrics include a P/E ratio of 24.80, a price-to-book (P/B) ratio of 1.17, and a trailing twelve-month dividend yield of 3.02%.
The company trades under the ticker ICL.